SOX2 and central nervous system cancer: They further showed that in Sox2-negative glioma cell lines, treatment with the DNA methyl-transferase inhibitor, 5-azacitidine (5-AZA), resulted in increased Sox2 expression at the mRNA and protein levels, whereas treatment with TSA had no such effect [52].